Source:
Sydney Morning HeraldTHE first malaria vaccine to use the whole parasite, developed by Australian researchers, will be tested on humans early next year in the US. The live vaccine, which will be used on a dozen volunteers in Maryland in February, has been created by genetically altering the parasite so it is unable to get into the blood stream, where it does the damage. Tests of similar vaccines on mice have shown 100 per cent protection against malaria, a crippling disease that kills more than 1 million people worldwide each year.
Alan Cowman, who heads the infection and immunity division at the Walter and Eliza Hall Institute in Melbourne, said he was confident the vaccine would prove safe for humans. ‘‘This vaccine will give people a live parasite which can’t cause malaria,’’ he said. That allows people to develop antibodies and the right immune response that will give immunity.’’
An article published in the current issue of the
Proceedings of the National Academy of Sciences outlines how the researchers deleted two key genes in the Plasmodium falciparum parasite that causes the form of malaria most deadly to humans. In identifying and deleting the genes, scientists have in effect created a weakened strain of the disease.
Volunteers in the first human trials, to take place at the Walter Reed Army Institute of Research, will have the vaccine delivered by mosquitoes. A second round of trials will involve delivery of the vaccine by injection. Professor Cowman said he was disappointed not to be taking part in the trials, injecting himself with the vaccine that he has worked for more than a decade to create. ‘‘We made it, and it would be really nice to be able to test it on ourselves,’’ he said. ‘‘But I would have to be in the US for eight weeks, and it’s just too long.’’
Read more:
http://www.smh.com.au/national/malaria-vaccine-will-be-a-first-20090728-e06d.html